chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3 days post vaccination - burning in hands, followed by increased nerve impulses in hands and feet.  Patient was given 2 rounds of prednisone to calm the reaction, with not much relief.  Patient became unable to use right arm/hand for fine motor skills, and had to learn to use left hand for writing, eating, etc.  Patient was started on increasing doses of gabapentin in February 2022, and continues to take it.  He has recovered some use of his right hand and arm, but it has not improved 100%.
12 hours after injection I had a fever (highest 102 F), body aches, chills, nausea, and injection site pain that lasted 3 days. On day three I developed injection site redness that grew for 2 days then went away. I self treated with tylenol, ibuprofen, and cold packs.
Pt. reports severe joint pain in arm that he did not receive the vaccine. He states it started about 3 hours to 4 1/2 hours after immunization. He reports it initially felt achy but by the next day got significantly worse. He reports that he does not have full strength in his arm and it is very painful to raise arm. Pt followed up with Primary Care doctor.
This is an initial spontaneous report from a contactable consumer. This is the first of two reports from a female consumer who reported for her currently 4 month year old son who was administered the first dose of PREVNAR 13, at 10-weeks-old. The vaccine was administered at 11:15 on 22Nov2010, in his thigh, for pneumonia and meningitis. Relevant medical history was none. Relevant concomitant medications were none. Vaccines given on the same day was unknown. Vaccines taken within the last four weeks included hepatitis b vaccine, human immunodeficiency virus vaccine, diphtheria vaccine, pertussis vaccine, tetanus vaccine and rotavirus vaccine. On 23Nov2010, the patient experienced bronchitis, fever, cough and was sick. He was taken to the emergency room on 07Dec2010 and was admitted for five hours. Treatments were not reported. The outcome was unknown.
Headache, Fever, NauseaVomiting, chills fever 101.7. pain at inj site with axillary lymph N/V, H/A
Information has been received regarding a case in litigation concerning an approximately 24 month old male who was injected IM with vaccinations containing the mercury based preservative thimerosal. The alleged results of the vaccinations is the patient suffered mercury toxicity and permanent neurological injuries, and associated complications with aggravation of other conditions directly through exposure of mercury. In approximately March 1999, at approximately 24 months of age, the patient suddenly regressed developmentally, losing milestones of neurological development previously achieved specifically including but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and loss of language skills, motor skills and affect. Immunization information indicated that the patient was injected with the following vaccines that contained thimerosal: Hepatitis B vaccine recombinant (yeast) on 4/24/97 (lot #61200/1554D), 7/24/97 (lot #621001/0052E) and 12/26/97 (lot # 1036t-invalid). Concomitant therapy included alum, potassium (+) diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid (TRIPEDIA) on 6/22/98 (lot #0932710); influenza virus vaccine (FLUZONE) on 9/28/99 (lot # U0063AA) and 10/29/99 (lot #U0063AA); diphtheria toxoid/pertussis vaccine/teta (TRI-IMMUNOL) on 5/23/97 (lot #444259), 7/24/97 (lot # 444255), 9/25/97 (lot #446456); and HIB conjugate vaccine (HIBTITER) on 5/23/97 (lot #M300PN), 7/24/97 (lot #M235RA) and 9/25/97 (lot # M256RP). Upon internal review, the patient's mercury poisoning and neurological disorder were considered to be an other important medical event. No further information is available.
Sore arm; Fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 65 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Aug2021 10:30 (Lot number: FC3183) at the age of 65 years as dose 1, single for covid-19 immunization. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Flu vaccine (Adverse event to a flu vaccine 30 years ago.), administration date: 1991, for Immunization, reaction(s): "fatigue", "did not feel well", "Sore arm", "Pneumonia". The following information was reported: FATIGUE (non-serious) with onset 30Aug2021 14:00, outcome "not recovered", described as "Fatigue"; PAIN IN EXTREMITY (non-serious) with onset 30Aug2021 18:00, outcome "not recovered", described as "Sore arm".  No follow-up attempts are possible. No further information is expected.
Initially it was uncertainty of putting weight on my ankle. Now I need to walk slow through an area. In a grocery store, now I would need to have a cart, as opposed to walking with just a hand basket. So I guess it's just the uncertainty of me being able to put weight on my ankle. So they, my job, told me basically to go see a doctor and get better. They wont let me back into the plant cause I cant basically walk now.
This spontaneous report as rreceived from a 81 year old female patient with allergies refers to herself. On 25-SEP-2006 the patient was vaccinated with ZOSTAVAX injection for shingles prevention. On 02-OCT-2009, the patient developed shiingles in her genital area. The patient recovered 6 weeks later (13-NOV-2009) after receiving the shingles on 02-OCT-2009. The physician in the physician AE drop down field was not the one who gave the patient the ZOSTAVAX vaccine. Additional information has been requested.
Muscle pain; Joint pain; she was having pain in her left side and that went to her leg, when she was walking it hurt; she was having pain in her left side and that went to her leg, when she was walking it hurt; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right arm on 18Jun2021 (Lot Number: EW0185) as dose 2, single at the age of 55-year-old for covid-19 immunisation. Concomitant medications were not reported. Historic vaccine was bnt162b2 received via an unspecified route of administration, administered in right arm on 28May2021 as dose 1, single at the age of 55-year-old for covid-19 immunization. The patient got her BioNTech Covid-19 Vaccine first shot on "2852021" (not clarified) and got her last (dose) on 18Jun2021. Since she had Covid vaccine she had muscle pain and joint pain like that. She did not know what was wrong about with her left she was having pain in her left side and that went to her leg, she did not know what was causing. She was applying cream (treatment) just while ago, she had muscle pain and joint pain and she was not sure. She was trying to figure out what was causing. When probed for event start date, the patient stated, she saw this pain about 3-4 weeks ago. (Further not clarified. Hence, not captured in the tab). The patient added, That was all she was not worried and she was just confirming that she said just kind of when she was walking it hurt, she wanted make sure if not vaccine was causing it. No any prior vaccination. Therapeutic measures were taken as a result of events which included cream. The outcome of events was not recovered.
MENQUADFI given orally to a 4 month old patient with no adverse event; Initial information received on 29-Aug-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves a 4 months old male patient to whom menquadfi given orally to a 4 month old patient with no adverse event while receiving vaccine meningococcal A-C-Y-W135 (T conj) vaccine [Menquadfi].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included pneumococcal vaccine conj 13V (CRM197) (Prevnar 13) for Immunisation; and diphtheria vaccine toxoid, HIB vaccine conj (TET TOX), pertussis vaccine acellular 5-component, polio vaccine inact 3V (MRC 5), tetanus vaccine toxoid (Pentacel) for Immunisation.  On 26-Aug-2022, the patient received 0.5 mL dose of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine (formulation and strength not reported; lot U7373AA, expiry date: 06-Aug-2022) via oral route for prophylactic vaccination.  On 26-Aug-2022, (latency: same day) the patient had a non-serious menquadfi given orally to a 4 month old patient with no adverse event (incorrect route of product administration) following the administration of meningococcal A-C-Y-W135 (T conj) vaccine.  It was reported, they have with giving MENQUADFI orally to a 4 month old infant.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Extremely itchy rash on Left arm that subsequently spread to my chest, front torso & back.
SUSPECTED IMMUNOLOGICAL VACCINATION FAILURE; This spontaneous report was received from a consumer and concerned a female of an unspecified age and unknown race and unknown ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number and expiry date were Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Company is unable to perform follow-up to confirm batch/lot number. No concomitant medications were reported. It was also reported that the patient and her husband were vaccinated on same day apart from each other. The patient was received the JnJ vaccine and her husband received Moderna. The patient stated that, on an unknown date, they both had got their antibodies were tested and the patient test was negative (suspected immunological vaccination failure ) and her husband test was found positive.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected immunological vaccination failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210358593-covid-19 vaccine ad26.cov2.s -Suspected Immunological failure. This event(s) is considered not related. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
started to get menstrual spotting on 06May2021; The patient is with seasonal/pollen allergy; This spontaneous case was reported by a consumer and describes the occurrence of SEASONAL ALLERGY (The patient is with seasonal/pollen allergy) and INTERMENSTRUAL BLEEDING (started to get menstrual spotting on 06May2021) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included Birth control pill and ESCITALOPRAM for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced SEASONAL ALLERGY (The patient is with seasonal/pollen allergy). On an unknown date, the patient experienced INTERMENSTRUAL BLEEDING (started to get menstrual spotting on 06May2021).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Case number PHEH2014US024951, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 82-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 30 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Pt has history of feeling faint/ dizzy with needles.  She felt fine before and during immunization.  She went to sit on bench while husband receiving his vaccine.  She then felt nausea/dizziness.  She laid down on bench, used cold compress, husband held her hand for 5 minutes or so, then she felt better.  She stated she thinks it was just a delayed anxiety reaction.  She was concerned about getting vaccine, then once all was finished symptoms presented.  She felt better shortly after.
I woke up from sleep with itchy palms & feet. When I itched my palms & feet, no rash but the itch continued until I took a hot shower.  I took 25 mg benadryl prior to entering a hot shower.  while in the shower, I became dizzy & sat down until I could exit the shower after 10 minutes.  I was so dizzy I could not stand in the shower..  After the shower, I took another 25 mg benadryl & one ranitidine 150 mg tablet.  At 6 am, the symptoms had resolved except for edema in both hands.
Event occurred after 2nd Dose. The patient presents with chest pain, She started having left chest pain 12/10/2021 and was brought in by EMS  Aspirin, Tylenol  Discharged home
Tachycardia HR 150s for 10 minutes associated with headache that awoke patient from sleep. Self resolved. EKG normal later that day and cardiac exam normal
Side effects; This case was reported by a physician via call center representative and described the occurrence of adverse event in an unspecified number of the adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The physician reported that the many patients have side effects after 1st dose of Shingrix and were reluctant to take the 2nd dose of Shingrix. Additional details regarding type of side effects or other information were not provided in the inquiry.
7/13/06: WELL CHILD VISIT. PAST WEEK SPITTY & GAGGY. NO VOMITING, NON BILIOUS, NON BLOODY. STOOLS GREEN JELLY LIKE WITH BLOOD STREAKS, NO FEVER, FEEDING WELL. DX: APPEARS TO BE GERD POSSIBLY WITH VIRAL ENTERITIS OR BREAT MILK COLITIS.  PLAN: CBC & STOOL O AND P. HOLD VACCINES UNTIL LAB RESULTS 7/20/06: NO RECURRENCE OF BLOOD IN STOOL.  OK FOR IMMS.  2M IMMS ADMIN. 9/14/06: 3M WELL CHILD VISIT. BORN W/ASSYMETRIC FACES SYNDROME. NO GROWTH CONCERNS.  4M IMMS ADMIN. 10/25/06: MOC CALLED STATING BABY GAGS AND SPITTING AFTER FEEDING.  TRIED ZANTAC IN PAST WITHOUT RELIEF SO STOPPED.  LAST VOID IN AM. 10/26/06, 10:15AM: FOC STATES CHILD VOMITING 4X DAY FOR PAST 2 DAYS MOSTLY AFTER BREASTFEEDING FORMULA.  BROUGHT CHILD INTO ED. 2 DAYS AGO HAD X1 LARGE STOOL.  INTERMITTENT FUSSINESS. AM X 1 BLOODY STOOL.  NO FEVER OR URI SXS. DX: INTUSSUSCEPTION, INCOMPLETE REDUCTION BY AIR ENEMA. PLAN: ADMIT OR FOR INTUSSUSCEPTION REDUCTION PROCEDURE: RQL LIMITED LAPAROTOMY W/ILEOCOLIC INSTUSSUSCEPTION REDUCTION.  APPENDECTOMY.  NO COMPLICATIONS.  DISCHARGED. 11/16/06: 6M WELL CHILD VISIT.  HAD INTUSSUCEPTION, BUT DOING WELL.  EATING SOLIDS, NO CHRONIC DIARRHEA OR CONSTIPATION.  IMMS ADMIN, BUT ROTAVIRUS HELD. 12/12/06 Received medical records from hospital which reveal patient presented to ER s/p 36 hours of vomiting, fussiness & then 1 bloody diaper on 10/26/06. Air enema revealed incomplete reduction of ileocolic IS which was initially present at the sigmoid level & reduced to the hepatic flexure.  Taken to OR & findings revealed distal ileum & appendix intussuscepted within right colon extending to mid transverse level which was reduced w/o difficulty & appendix removed.  D/C to home on 10/28/06. Final DX: Intussusception, surgically reduced.
12/26/2022 around that late morning, I noticed a scratchy throat. Then later it almost got to feel like Laryngitis. The next day It was a lot of gas in the trunk of my body and my throat was still scratchy. On 12/28/2022, I was having nausea and diarrhea. I was having dry heaves, vomiting. I had terrible body aches the whole time. I took TYLENOL for that; I was in bed for four and a half days. There was a lot of congestion. I took a home COVID-19 test, it was positive. I contacted my doctor and he prescribed PAXLOVID. Even when taking the PAXLOVID I was still having extreme bouts of nausea and diarrhea. I am having congestion and I am really tired. I have congestion and it's making my voice really raspy.
After 1st dose burning rash below injection site  After 2nd dose burning rash below the site with a diffuse burning sensation over skin, high fever and persistent GI and cutaneous issues following the vaccination
Severe stomach pains and vomiting.  Vomited 12 times within 2 hours. Severe stomach pains subsided after 1.5 hour, but vomiting continued. Stomach pains so severe that she was writhing on the floor and in bed.  After 3 hours, no additional vomiting or pains.
herpes zoster; detached retina; Information has been received from lawyers referring to a female patient of unknown age. The patient's medical history, concurrent condition and concomitant therapy were not reported.  On or around 11-OCT-2016, the patient was vaccinated with Zoster Vaccine Live (ZOSTAVAX) (strength, dose, frequency, route, lot# and expiration date were unknown) for the prevention of shingles (herpes zoster) and routine health maintenance.   On an unknown date, the patient suffered facial swelling, left sided facial redness, pain which radiated down left jaw and into her neck, and crusting lesions along ophthalmic nerve. The patient was ultimately diagnosed with herpes zoster and detached retina. The patient did not recover from the events. As per the reporter, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The events were disabling.   The reporter considered the events were related to Zoster Vaccine Live (ZOSTAVAX).  Upon internal review, the event of detached retina was determined to be medically significant.
pt noticed an itchy rash starting on elbows 15JUN96 3PM which gradually spread;pt states taking DPH;describes rash as clustered bumps appear like orange peel texture;
I made an appointment to get my first Dose of Covid Vaccine. Being Needle phobic, I had to really meditate and get myself in the right head space to get this vaccine. When I arrived I was told that my schedualed appoinmtnet did not matter and that I needed to come back a differnt day. I told the Pharmasist that I  had a conformation number and that the store was welcoming walk-ins. He then said "I'm sure you do. I can give you the Vaccine but I'm going to make you make the choice. There are people dieing in India wanting this Vaccine, as soon as I open this vial 8 does will have to be thrown away so that YOU can have your shot. I dont want that on my conscience. Can you?" I felt incredible uncomftorble and like I was being turned away. I never heard of any one going to get the vaccine and being threated that they will harm others or that its my resposablity. I am tramatized.
Clinical deviation: Pfizer mixed with Janssen.  It was discovered that patient received Janssen COVID-19 vaccine on 3/18/21.  Came to our clinic and received a subsequent Pfizer dose 8/15/21 and another Pfizer 9/19/21.  Mix was not discovered until administration of Pfizer on 9/19/21.  F/U attempted with patient; no response.
she experienced a lack of taste and smell; she experienced a lack of taste and smell; This is a spontaneous report.  This consumer is reported for her granddaughter. A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) at an unspecified age, via an unspecified route of administration on 09Jun2021 as 2nd dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 for COVID-19 immunization on an unspecified date. On 10Jun2021, the patient experienced a lack of taste and smell. The reporter wanted to know if they have heard of this happening. The doctor and pharmacist said that was not normal and she could not find information on this on google. The outcome of the events was unknown.  Follow-up attempts have been completed and no further information is expected.
37 year old male vaccinated for deployment in February 2003.  In January 2003 he received MMR, anthrax, and yellow fever vaccines.  On 8 February, he received MMR again even though he had his medical records with him, and anthrax vaccine.  He developed a low grade fever, generalized aches and pains immediately after receipt of the immunization.  On the fifth day he developed "severe" pain for which he took aspirin and ibuprofen with some relief.  He also developed constipation alternating with diarrhea, hematuria and dysuria for the next two weeks.  On the evening of 24 February he could not sleep due to severe abdominal pain and cramping.  The pain started on the right side and then spread to the entire abdomen.  He went to the emergency room and was admitted for observation.  He was transferred to the hospital where he underwent an exploratory laparoscopy.  His appendix was removed, but was not inflamed.  He continued to have abdominal pain that was similar to the pain experienced before surgery.  He was told that this was a direct result of the gas used for the laparoscopic procedure.  He continued to have chills, low grade fever and aches.  He was transferred back.  He deployed, but was sent back to deal with family issues.  His abdominal pain was 6-7 on a 0-10 pain scale for the October 2003 to January 2004 time period.  During this time, he also noted muscle spasms and twitching that progress until he has pain in the affected muscles (upper and lower extremities). He had increased fatigue until January or February 2004 when he started running 1 1 ½ miles a day.  He was able to continue this activity until April 2004 when he developed dizziness, nausea, shortness of breath and "spotty" vision with exercise.  From April to August 2004 he started to feel achy, run down, and short of breath, "like I had the flu".  During this time, his abdominal pain was sporadic, only occurring once or twice a month.  He had a sigmoidoscopy in April or June 2004 that identified mild diverticulosis.  In August 2004 he received his second anthrax vaccine.  Shortly afterwards, he developed a recurrence of the abdominal pain.  He was also treated for anxiety and depression.  Headaches also developed after the second anthrax vaccine.  These headaches are accompanied by lightheadedness, dizziness, and a low grade fever.  He has not been able to identify a trigger for the headaches or anything that will relieve them.  He continues to have intermittent, migrating, needle-like sensation in his shoulders, thighs and forearms. He has also noted swelling of the knee, ankle, arm, and finger joints bilaterally.  He now uses a cane to walk secondary to disequilibrium, "spongy" leg muscles, and arthralgias in his knees and ankles.